Members
Members
Cores
Projects
Observational Study Monitoring Board
Director of the SF Coordinating Center is the corresponding PI of the Consortium and PI of the Administrative Core
SF Coordinating Center, San Francisco, CA
Email: steven <dot> cummings <at> ucsf <dot> edu
Mobile: (415) 203-2864
Administrative Assistant: Christina Kouma: ckouma@sfcc-cpmc.net
PI for scientific activities of the Consortium, overseeing the progress of assays, analyses, reports and publications, and PI of Disease Context Project
TGen, Phoenix, AZ
Email: nschork@tgen.org
Moblie: (858) 922-3448
Project Director for LC
Institute for Systems Biology, Seattle
Email: jdougherty <at> systemsbiology <dot> org
Co-Investigator of the Administrative Core, providing expertise in human subjects data sharing and protection.
SF Coordinating Center, San Francisco, CA
Email: daniel <dot> evans <at>ucsf <dot> edu
Co-Investigator of the Administrative Core, contributing to phenotype selection and harmonization.
University of Pittsburgh, School of Public Health
Email: newmana <at> edc <dot>pitt <dot> edu
National Institute on Aging (NIA)
NIA / Director, Division of Geriatrics and Clinical Gerontology
Email: ehadley <at> mail <dot> nih <dot> gov
NIA / Chief, Clinical Gerontology Branch
Email: duttac <at> nia <dot> nih <dot> gov
NIA/NIH Program Officer / Health Scientist Administrator
Email: nalini <dot> raghavachari <at> nih <dot> gov
PI of Chemoinformatics Core
University of California, Riverside
Email: thomas.girke@ucr.edu
PI of Systems Biology Core
Institute for Systems Biology, Seattle
Email: noa <dot> rappaport <at> systemsbiology <dot> org
PI of Centenarian Project
Boston University School of Medicine
Email: thperls <at> bu <dot> edu
PI of Centenarian Project
Tufts University School of Medicine
Email: psebastiani <at> tuftsmedicalcenter <dot> org
Co-Investigator of the Centenarian Project
Boston University
Email: stacy<at> bu <dot> edu
Co-Investigator of the Centenarian Project
Oregon State University
Email: Harold <dot> Bae <at> oregonstate <dot> edu
Co-Investigator of the Centenarian Project
Tufts University School of Medicine
Email: agurinovich <at> tuftsmedicalcenter <dot> org
Co-Investigator of the Centenarian Project
Boston University
Email: smonti <at> bu <dot> edu
The Disease Context Project PI is Nik Schork, Scientific PI of the Longevity Consortium (see Admin Core, above)
PI of Metabolomics Project
University of California, Davis
Email: ofiehn <at> ucdavis <dot> edu
PI of Mice/Cell Project
University of Michigan Medical School, Ann Arbor
Email: millerr <at> umich <dot> edu
PI of Proteomics Project
Oregon Health & Science University (OHSU)
Email: lapidusj <at> ohsu <dot> edu
PI of Proteomics Project
Oregon Health & Science University (OHSU)
Email: orwoll <at> ohsu <dot> edu
PI of Proteomics Project
Institute for Systems Biology, Seattle
Email: rmoritz <at> systemsbiology <dot> org
Chair, Department of Computational Biomedicine,
Cedars-Sinai Medical Center, Los Angeles, California
Email: jhmoore <at> csmc <dot> edu
Artificial intelligence, bioinformatics, biomedical informatics, complex adaptive systems, data science, epistasis, genetic architecture, genetic epidemiology, genomics, human genetics, machine learning, network science, precision medicine, simulation, systems biology, translational bioinformatics, visualization, visual analytics
Distinguished Professor, Department Chair
University of Alabama at Birmingham
Email: austad <at> uab <dot> edu
The long-term goal of my research is to develop treatments to slow the aging process, thus keeping people fit and healthy longer. My laboratory works with different animal species, especially those which are more successful at aging than humans. We work on exotic species, like clams that live more than 500 years, and hydra that don’t age at all, in order to discover such treatments. We also develop measures of laboratory animal health, so that we can assess whether a treatment that makes a mouse live longer also improves the quality of its life. Finally, it has been discovered in recent years that the sexes often respond very differently to treatments than extend life and health. Something that dramatically slows aging in one sex may have no effect on the other sex. We have recently begun exploring why this is so.
Professor of Biotechnology
University of Tartu
Andres <dot> metspalu <at> ut <dot> ee
Dr. Metspalu's major fields of research are genomics and genetic engineering, human genome research methods for large variation in gene banks; genetics and complex diseases, the relationship of genes, environmental factors, lifestyle, and state of health between the molecular and genetic analysis in developing the technology of DNA chip technology.
Founding director of the Glenn Biggs Institute for Alzheimer’s & Neurodegenerative Diseases
UT Health San Antonio
Email: Suseshad <at> bu <dot> edu
My research focuses on 4 interrelated areas: (a) exploring the correlates of subclinical brain aging including establishing norms for brain MRI and cognitive test performance and relating these measures to novel risk factors (such as visceral fat mass), multiple circulating biomarkers and clinical and subclinical indices of vascular and metabolic disease; (b) the epidemiology of stroke and vascular cognitive impairment including the lifetime risk of stroke, cognitive decline and dementia following stroke, the role of parental stroke and midlife risk factors in determining late-life stroke risk and temporal trends in stroke risk over the past 50 years; (c) the epidemiology of dementia and Alzheimer’s disease (AD) including describing the lifetime risk of AD and relating traditional and novel biomarkers (homocysteine, lipids, diabetes, estrogen, bone mineral density, thyroid function, inflammation) to the risk of dementia and AD.
Associate professor in the Department of Biochemistry and Neurology, Scientific Director of the Emory Integrated Proteomics Core
Emory University
Email: nseyfriend <at> emory <dot> edu
Research in the Seyfried lab is focused on the integration of proteomics, systems biology, and molecular biology to tackle fundamental questions related to the pathogenesis of Alzheimers Disease (AD) and other neurodegenerative disorders. In particular, his lab utilizes high resolution liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) to identify and quantify proteins and post-translational modifications (PTMs). Combining tools in both molecular and cellular biology, they also explore the relationship between the function of these proteins and their PTMs in the development of these devastating diseases.